By Associate Professor Amany Zekry

Journal articles

Finn RS; Qin S; Ikeda M; Galle PR; Ducreux M; Kim T-Y; Kudo M; Breder V; Merle P; Kaseb AO; Li D; Verret W; Xu D-Z; Hernandez S; Liu J; Huang C; Mulla S; Wang Y; Lim HY; Zhu AX; Cheng A-L, 2020, 'Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma', NEW ENGLAND JOURNAL OF MEDICINE, 382, pp. 1894 - 1905, http://dx.doi.org/10.1056/NEJMoa1915745

Abd-Elaty E; Zekry A; El-Agooz S; Helaly AM, 2020, 'Cognitive Radio Techniques for Utilizing the Primary L-Band Distance Measuring Equipment for Aeronautical Communications', IEEE Access, 8, pp. 124812 - 124823, http://dx.doi.org/10.1109/ACCESS.2020.3007741

Salem MS; Alzahrani AJ; Ramadan RA; Alanazi A; Shaker A; Abouelatta M; Gontrand C; Elbanna M; Zekry A, 2020, 'Physically Based Analytical Model of Heavily Doped Silicon Wafers Based Proposed Solar Cell Microstructure', IEEE Access, 8, pp. 138898 - 138906, http://dx.doi.org/10.1109/ACCESS.2020.3012657

Nicoll AJ; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy M; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser SI; McCaughan GW, 2019, 'Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels', Alimentary Pharmacology and Therapeutics, 49, pp. 1314 - 1322, http://dx.doi.org/10.1111/apt.15248

Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR, 2019, 'Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection', Journal of Infectious Diseases, 219, pp. 1430 - 1438, http://dx.doi.org/10.1093/infdis/jiy679

Brown MA; Gellatley W; Hoffman A; Dowdell L; Camac A; Francois R; Boston B; Zekry A, 2019, 'Medical complications of homelessness: a neglected side of men’s health', Internal Medicine Journal, 49, pp. 455 - 460, http://dx.doi.org/10.1111/imj.14139

Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013

Chidwick K; Kiss D; Gray R; Yoo J; Aufgang M; Zekry A, 2018, 'Insights into the management of chronic hepatitis C in primary care using MedicineInsight', Australian journal of general practice, 47, pp. 639 - 645, http://dx.doi.org/10.31128/AJGP-02-18-4482

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L, 2018, 'Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy', Journal of Clinical Nursing, 27, pp. 2673 - 2683, http://dx.doi.org/10.1111/jocn.14367

Brown A; Hézode C; Zuckerman E; Foster GR; Zekry A; Roberts SK; Lahser F; Durkan C; Badshah C; Zhang B; Robertson M; Wahl J; Barr E; Haber B, 2018, 'Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE study', Journal of Viral Hepatitis, 25, pp. 457 - 464, http://dx.doi.org/10.1111/jvh.12801

Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G, 2018, 'Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy', Clinical Gastroenterology and Hepatology, 16, pp. 268 - 277, http://dx.doi.org/10.1016/j.cgh.2017.09.063

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L, 2018, 'Factors associated with non-adherence to HBV antiviral therapy', Antiviral Therapy, 23, pp. 425 - 433, http://dx.doi.org/10.3851/IMP3219

Sud R; Tiwari N; Forner P; Dowdell L; Freiman J; Zekry A, 2018, 'General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C', Internal Medicine Journal, 48, pp. 105 - 106, http://dx.doi.org/10.1111/imj.13662

Nicoll A; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy MT; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser S; McCaughan G, 2018, 'Mo1458 - Response to Mycphenolate Mofetil in Patents with Autoimmune Hepatitis who Fail Standard Therapy is Predicted by Serum Gammaglobulin Levels but not Cirrhosis', Gastroenterology, 154, pp. S - 1213, http://dx.doi.org/10.1016/s0016-5085(18)34006-x

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011

Polis S; Zhang L; Mainali B; Pons R; Pavendranathan G; Zekry A; Fernandez R, 2017, 'Factors associated with medication adherence in patients living with cirrhosis (vol 25, pg 204, 2016)', JOURNAL OF CLINICAL NURSING, 26, pp. 3751 - 3751, http://dx.doi.org/10.1111/jocn.14074

Polis S; Zablotska-Manos I; Zekry A; Maher L, 2017, 'Adherence to Hepatitis B antiviral therapy: A qualitative study', Gastroenterology Nursing, 40, pp. 239 - 246, http://dx.doi.org/10.1097/SGA.0000000000000161

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; Dore GJ; George J; Maher L, 2017, 'Factors associated with HBV virological breakthrough', Antiviral Therapy, 22, pp. 53 - 60, http://dx.doi.org/10.3851/IMP3087

Lubel J; Strasser S; Stuart KA; Dore G; Thompson A; Pianko S; Bollipo S; Mitchell JL; Fragomeli V; Jones T; Chivers S; Gow P; Iser D; Levy M; Tse E; Gazzola A; Cheng W; Nazareth S; Galhenage S; Wade A; Weltman M; Wigg A; MacQuillan G; Sasadeusz J; George J; Zekry A; Roberts SK, 2017, 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study', Antiviral Therapy, 22, pp. 699 - 710, http://dx.doi.org/10.3851/IMP3168

Lee A; Rode A; Nicoll A; Zekry A; Lim L; Lim S; Angus P; Kronborg I; Arachchi N; McCaughan G; McLennan S; Shackel N, 2017, 'Soluble CD147 has an altered expression profile with liver disease progression and in different ethnicities', JOURNAL OF HEPATOLOGY, 66, pp. S658 - S658, http://dx.doi.org/10.1016/S0168-8278(17)31783-X

Dowdell L; Zekry A, 2017, 'P13 Call: community assessment and liver liaison, a liver clinic provided to homeless men in their community', Journal of Virus Eradication, 3, pp. 16 - 17, http://dx.doi.org/10.1016/s2055-6640(20)30754-8

Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576

Chen FW; Zekry A, 2016, 'Elevated serum ferritin: Identifying iron overload', Medicine Today, 7, pp. 51 - 52

Williams KH; Vieira De Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Brooks B; Bu Y; Cavanagh E; Raleigh J; Mclennan SV; Mccaughan GW; Keane FM; Zekry A; Gorrell MD; Twigg SM, 2015, 'Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study', Journal of Diabetes, 7, pp. 809 - 819, http://dx.doi.org/10.1111/1753-0407.12237

Zeuzem S; Flisiak R; Vierling JM; Mazur W; Mazzella G; Thongsawat S; Abdurakhmanov D; Van Kinh N; Calistru P; Heo J; Stanciu C; Gould M; Makara M; Hsu S-J; Buggisch P; Samuel D; Mutimer D; Nault B; Merz M; Bao W; Griffel LH; Brass C; Naoumov NV, 2015, 'Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II)', ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 42, pp. 829 - 844, http://dx.doi.org/10.1111/apt.13342

Zhu AX; Park JO; Ryoo B-Y; Yen C-J; Poon R; Pastorelli D; Blanc J-F; Chung HC; Baron AD; Pfiffer TEF; Okusaka T; Kubackova K; Trojan J; Sastre J; Chau I; Chang S-C; Abada PB; Yang L; Schwartz JD; Kudo M, 2015, 'Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial', LANCET ONCOLOGY, 16, pp. 859 - 870, http://dx.doi.org/10.1016/S1470-2045(15)00050-9

Williams KH; Viera de Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Bu Y; Brooks B; Cavanagh E; Raleigh J; McLennan SV; McCaughan GW; Bachovchin WW; Keane FM; Zekry A; Twigg SM; Gorrell MD, 2015, 'Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity', Diabetes Research and Clinical Practice, 108, pp. 466 - 472, http://dx.doi.org/10.1016/j.diabres.2015.02.024

Sievert W; Razavi H; Thompson A; Zekry A; Dore GJ; Roberts SK, 2015, 'HCV‐infected patients need access now to new direct‐acting antiviral agents to avert liver‐related deaths', The Medical Journal of Australia, 202, pp. 479 - 479, http://dx.doi.org/10.5694/mja15.00165

Muir AJ; Arora S; Everson G; Flisiak R; George J; Ghalib R; Gordon SC; Gray T; Greenbloom S; Hassanein T; Hillson J; Horga MA; Jacobson IM; Jeffers L; Kowdley KV; Lawitz E; Lueth S; Rodriguez-Torres M; Rustgi V; Shemanski L; Shiffman ML; Srinivasan S; Vargas HE; Vierling JM; Xu D; Lopez-Talavera JC; Zeuzem S, 2014, 'A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection', Journal of Hepatology, 61, pp. 1238 - 1246, http://dx.doi.org/10.1016/j.jhep.2014.07.022

Raghuraman S; Lloyd AR; Zekry A, 2014, 'Obese visceral adipose tissue exhibits altered T cell trafficking patterns and confers a unique phenotype to tissue-resident T cells', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bruggmann P; Berg T; Øvrehus ALH; Moreno C; Brandão Mello CE; Roudot-Thoraval F; Marinho RT; Sherman M; Ryder SD; Sperl J; Akarca U; Balık I; Bihl F; Bilodeau M; Blasco AJ; Buti M; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hézode C; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marotta P; Mauss S; Mendes Correa MC; Müllhaupt B; Myers RP; Negro F; Nemecek V; Örmeci N; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Rosenberg WM; Sarmento-Castro R; Sarrazin C; Semela D; Shiha GE; Sievert W; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; van Thiel I; Van Vlierberghe H; Vandijck D; Vogel W; Waked I; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Van Damme P; Aleman S; Hindman SJ, 2014, 'Historical epidemiology of hepatitis C virus (HCV) in selected countries', Journal of viral hepatitis, 21, pp. 5 - 33, http://dx.doi.org/10.1111/jvh.12247

Wedemeyer H; Duberg AS; Buti M; Rosenberg WM; Frankova S; Esmat G; Örmeci N; Van Vlierberghe H; Gschwantler M; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; El-Sayed MH; Ergör G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Guimarães Pessôa M; Hézode C; Hindman SJ; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marinho RT; Marotta P; Mauss S; Mendes Correa MC; Moreno C; Müllhaupt B; Myers RP; Nemecek V; Øvrehus ALH; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Sarrazin C; Semela D; Sherman M; Shiha GE; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Vandijck D; Vogel W; Waked I; Weis N; Wiegand J; Yosry A; Zekry A; Negro F; Sievert W; Gower E, 2014, 'Strategies to manage hepatitis C virus (HCV) disease burden', Journal of viral hepatitis, 21, pp. 60 - 89, http://dx.doi.org/10.1111/jvh.12249

Razavi H; Waked I; Sarrazin C; Myers RP; Idilman R; Calinas F; Vogel W; Mendes Correa MC; Hézode C; Lázaro P; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Buti M; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hindman SJ; Hofer H; Husa P; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Marinho RT; Marotta P; Mauss S; Moreno C; Murphy K; Negro F; Nemecek V; Örmeci N; Øvrehus ALH; Parkes J; Pasini K; Peltekian KM; Ramji A; Reis N; Roberts SK; Rosenberg WM; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Semela D; Sherman M; Shiha GE; Sievert W; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Van Vlierberghe H; Vandijck D; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Cornberg M; Müllhaupt B; Estes C, 2014, 'The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm', Journal of viral hepatitis, 21, pp. 34 - 59, http://dx.doi.org/10.1111/jvh.12248

Martinez D; Palmer C; Simar D; Cameron B; Nguyen N; Aggarwal V; Lloyd A; Zekry A, 2014, 'Characterization of the cytokine milieu associated with the upregulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders', Liver International, http://dx.doi.org/10.1111/liv.12473

Roberts SK; Mitchell J; Leung R; Booth D; Bollipo S; Ostapowicz G; Sloss A; Mccaughan GW; Dore GJ; Thompson A; Crawford DH; Sievert W; Weltman M; Cheng W; George J; Angus P; Chu G; Cornwall M; Douglas M; Hallinan R; Haque M; Hawkin G; Jackson H; Johnson R; Kronborg I; Lee A; Leggett B; Mire ML; Levy M; Lubel J; MacQuillan G; Masson J; McDonald J; McGarity B; Mollison L; Nicoll A; Ombiga J; Riordan S; Strasser S; Thompson A; Watson J; Wenman J; Wigg A; Zekry A, 2014, 'Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 179 - 184, http://dx.doi.org/10.1111/jgh.12424

Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ, 2014, 'Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 1 - 9, http://dx.doi.org/10.1111/jgh.12677

Nguyen N; de Esch C; Cameron B; Kumar RK; Zekry A; Lloyd AR, 2014, 'Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 860 - 869, http://dx.doi.org/10.1111/jgh.12462

Nguyen N; Hampartzoumian T; Cameron B; Palmer C; O'Toole S; Post J; Zekry A; Lloyd A, 2014, 'Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 1535 - 1543, http://dx.doi.org/10.1111/jgh.12543

Nguyen N; Luciani F; Cameron B; Keoshkerian E; Zekry A; Lloyd A, 2012, '801 T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', Journal of Hepatology, 56, pp. S313 - S313, http://dx.doi.org/10.1016/s0168-8278(12)60813-7

Guirgis M; Nusair F; Bu YM; Yan KK; Zekry A, 2012, 'Barriers Faced by Migrants in Accessing Healthcare for Viral Hepatitis Infection.', Internal Medicine Journal, 42, pp. 491 - 496, http://dx.doi.org/10.1111/j.1445-5994.2011.02647.x

Guirgis M; Yan KK; Bu YM; Zekry A, 2012, 'General practitioners' knowledge and management of viral hepatitis in the migrant population.', Internal Medicine Journal, 42, pp. 497 - 504, http://dx.doi.org/10.1111/j.1445-5994.2011.02440.x

Yan K; Zekry A, 2011, 'Standard Therapy for Genotypes 2/3', , pp. 90 - 96, http://dx.doi.org/10.1002/9781444346343.ch12

Patel K; Jhaveri R; George J; Qiang G; Kenedi C; Brown K; Cates C; Zekry A; Tillmann HL; Elliott L; Kilaru R; Albrecht J; Conrad A; McHutchison J, 2011, 'Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C', Journal of Viral Hepatitis, 18, pp. 331 - 337, http://dx.doi.org/10.1111/j.1365-2893.2010.01310.x

Zeuzem S; Sulkowski MS; Lawitz EJ; Rustgi VK; Rodriguez-Torres M; Bacon BR; Grigorescu M; Tice AD; Lurie Y; Cianciara J; Muir AJ; Cronin PW; Pulkstenis E; Subramanian GM; Mchutchison JG, 2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1', GASTROENTEROLOGY, 139, pp. 1257 - 1266, http://dx.doi.org/10.1053/j.gastro.2010.06.066

Nelson DR; Benhamou Y; Chuang W-L; Lawitz EJ; Rodriguez-Torres M; Flisiak R; Rasenack JWF; Kryczka W; Lee C-M; Bain VG; Pianko S; Patel K; Cronin PW; Pulkstenis E; Subramanian GM; Mchutchison JG, 2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3', GASTROENTEROLOGY, 139, pp. 1267 - +, http://dx.doi.org/10.1053/j.gastro.2010.06.062

Palmer CS; Dehart M; Zhang X; Feilotter H; Lloyd A; Zekry A, 2010, 'miR-135a*plays a key role in regulating lipogenesis and inflammation in liver diseases', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, pp. A128 - A128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen N; De Esch C; Hampartzoumian T; Zekry A; Lloyd A, 2009, 'Fine positioning of T cell sub-populations in the chronic HCV-infected liver', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A284 - A284, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Palmer C; Zhang X; Feilotter H; Lloyd A; Zekry A, 2009, 'Hepatic micrornas expression in obese subjects with chronic HCV', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A285 - A285, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen N; Palmer C; Hampartzoumian T; Post J; Zekry A; Lloyd A, 2009, 'Intrahepatic chemokine expression and CD8+T cells in HIV/HCV co-infection compared to HCV mono-infection', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A289 - A289, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guirgis M; Zekry A; Yan K; Bu YM; Lee A, 2009, 'Chronic hepatitis B infection in an Australian antenatal population: Seroprevalence and opportunities for better outcomes', Journal of Gastroenterology and Hepatology (Australia), 24, pp. 998 - 1001, http://dx.doi.org/10.1111/j.1440-1746.2009.05841.x

Back to profile page